| Why carry out the study? |
| BIC/FTC/TAF and DTG + 3TC are potential therapies for HIV. |
| Both groups had excellent virological efficacy and immunological efficacy. |
| What was learned from the study? |
| The incidence of LLV was similar in the BIC/FTC/TAF and DTG + 3TC groups. |
| Changes in body weight, lipid metabolism, and liver and kidney function were similar, with good safety and tolerance. |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.